<DOC>
	<DOCNO>NCT01800396</DOCNO>
	<brief_summary>Background : The incidence gastrointestinal infection high . In Western country least 30 % population suffers least one food-borne infection per year . Mostly problem antibiotic resistance , emphasis put prevention infection . One possibilities strengthen human resistance gut infection consumption milk ingredient . Aim : To study whether milk protein concentrate rich phospholipid improves resistance human enterotoxigenic E. coli ( ETEC ) . Study design : The MIRAGE study parallel , double-blind , placebo-controlled 4-weeks intervention milk protein concentrate rich phospholipid healthy subject 18-55 yrs age . Participants randomly assign milk protein concentrate rich phospholipid placebo group ( n=30 per group ) . Subjects instruct maintain usual pattern physical activity habitual food intake , standardize dietary calcium intake . After adaptation period 2 week , subject orally infected live , attenuate , ETEC vaccine ( strain E1392-75-2A ; collection NIZO food research ; dose 1010 CFU ) . Before infection , online diary kept record food drink consumption ( 2x2 day ) assess habitual dietary intake . The diary also use daily record bowel habit frequency severity gastrointestinal complaint . The following biological sample collect : 4x10 ml venous blood , single fecal bolus ( screen ) 7x24 hr feces . Blood sample immune response analyse fecal sample collect quantify several infection- immune system marker verify dietary calcium intake . Saliva sample three time infection quantify immune system marker . Primary outcome : Fecal ETEC excretion severity diarrhea ( quantified fecal output per day ) . Secondary outcome : Serum immune response ETEC , self-reported stool consistency score gastrointestinal complaint , relative fecal wet weight .</brief_summary>
	<brief_title>Milk Ingredients Resistance Against E-coli-induced GastroEnteritis ( MIRAGE )</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Gastroenteritis</mesh_term>
	<criteria>Signed informed consent Age 1855 yr Availability internet connection Willingness replace habitual dairy product intake supplied lowcalcium soy product Willingness abstain product high amount prebiotic fiber product probiotic start 1 month prior study start Willingness give blood donation 1 month start experiment entire experimental period . Current previous underlie disease GI tract , liver , bile bladder , kidney , thyroid gland ( selfreported ) Allergy milk product lactose intolerance ( selfreported ) , since capsule may contain milk trace culture medium Allergy soy product ( selfreported ) Use antibiotic , norit , laxative ( till 6 month prior inclusion ) , cholestyramine , acid burn inhibitor immune suppressive agent ( till 3 month prior inclusion ) , pre probiotic ( till 1 month prior inclusion ) . High titer serum antibody ETEC ( 10 ml blood sample collect screen ) ETEC detect fecal sample ( collected screening ) Vegetarians Vegans Heavy alcohol use ( &gt; 4 consumptions/day &gt; 20/week ) Drug use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Bacterial infection</keyword>
	<keyword>Dairy</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>Diet</keyword>
	<keyword>E.Coli</keyword>
	<keyword>Gastroenteritis</keyword>
	<keyword>Milk</keyword>
	<keyword>Stool consistency</keyword>
</DOC>